copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Max Lataillade - Bill Melinda Gates Foundation | LinkedIn · Experience: Bill Melinda Gates Foundation · Education: Yale University School of Medicine · Location: New York City Metropolitan Area · 500+ connections on LinkedIn View Max Lataillade’s
Max Lataillade, MPH, DO - Yale School of Medicine Durable efficacy and robust CD4+ T-cell count improvement observed across age, race, sex, and geographic subgroups of heavily treatment-experienced people with multidrug-resistant HIV-1 after 240 weeks of fostemsavir treatment
CytoDyn Welcomes Dr. Lataillade as New Clinical Leader Who is Dr Max Lataillade? Dr Lataillade is the newly appointed Senior Vice President and Head of Clinical Development at CytoDyn, with over two decades of experience in research and drug development
Dr. Max Lataillade - Color Magazine Dr Max Lataillade is Head of Clinical Development for HIV, ViiV Healthcare where He is responsible for the development of new medicines that address key unmet medical needs for HIV patients
2024-10-08 | CytoDyn Appoints Dr. Max Lataillade as Senior Vice . . . VANCOUVER, Washington, Oct 08, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Max Lataillade, DO, MPH, has been appointed as Senior Vice President and Head of Clinical
CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head . . . CytoDyn Inc (OTCQB: CYDY) has appointed Dr Max Lataillade as Senior Vice President and Head of Clinical Development Dr Lataillade, with over 20 years of research experience, will lead the company's global R D strategy and oversee end-to-end R D activities
Leadership Team :: CytoDyn Inc. (CYDY) Max Lataillade, DO, MPH, currently serves as the Company’s Senior Vice President and Head of Clinical Development Dr Lataillade relies on his significant industry experience in leading the Company’s global research and development strategy and oversee end-to-end R D activities to advance the Company’s clinical development pipeline